Clinical Trials Browser

Leukemia, Myeloid, Acute × axatilimab × 90 days × Clear all

NCT07511062 2026-04-06

Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML

Phase 1 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute